130 related articles for article (PubMed ID: 7916183)
1. [Phase I clinical trial of RP 56976 (docetaxel) a new anticancer drug].
Taguchi T; Furue H; Niitani H; Ishitani K; Kanamaru R; Hasegawa K; Ariyoshi Y; Noda K; Furuse K; Fukuoka M
Gan To Kagaku Ryoho; 1994 Sep; 21(12):1997-2005. PubMed ID: 7916183
[TBL] [Abstract][Full Text] [Related]
2. [Late phase II trial of RP56976 (Docetaxel) in patients with non-small-cell lung cancer].
Onoshi T; Watanabe K; Furuse K; Kurita Y; Sugiura T; Sato K; Fujii M; Oizumi K; Abe S; Inoue Y
Gan To Kagaku Ryoho; 1995 Jan; 22(1):59-65. PubMed ID: 7826079
[TBL] [Abstract][Full Text] [Related]
3. [An early phase II clinical study of RP56976 (docetaxel) in patients with cancer of the gastrointestinal tract].
Taguchi T
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2431-7. PubMed ID: 7944488
[TBL] [Abstract][Full Text] [Related]
4. Phase I trial of docetaxel administered as a 1-hour infusion in children with refractory solid tumors: a collaborative pediatric branch, National Cancer Institute and Children's Cancer Group trial.
Blaney SM; Seibel NL; O'Brien M; Reaman GH; Berg SL; Adamson PC; Poplack DG; Krailo MD; Mosher R; Balis FM
J Clin Oncol; 1997 Apr; 15(4):1538-43. PubMed ID: 9193350
[TBL] [Abstract][Full Text] [Related]
5. [A late phase II clinical study of RP56976 (docetaxel) in patients with advanced or recurrent gastric cancer: a cooperative study group trial (group B)].
Mai M; Sakata Y; Kanamaru R; Kurihara M; Suminaga M; Ota J; Hirabayashi N; Taguchi T; Furue H
Gan To Kagaku Ryoho; 1999 Mar; 26(4):487-96. PubMed ID: 10097745
[TBL] [Abstract][Full Text] [Related]
6. [Early phase II clinical study of RP56976 (docetaxel) in patients with primary pulmonary cancer. Docetaxel Cooperative Study Group for Lung Cancer].
Yokoyama A; Kurita Y; Watanabe K; Negoro S; Ogura T; Nakano M; Minoda S; Niitani H; Taguchi T
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2609-16. PubMed ID: 7979421
[TBL] [Abstract][Full Text] [Related]
7. Phase II study of docetaxel in advanced soft tissue sarcomas.
Edmonson JH; Ebbert LP; Nascimento AG; Jung SH; McGaw H; Gerstner JB
Am J Clin Oncol; 1996 Dec; 19(6):574-6. PubMed ID: 8931674
[TBL] [Abstract][Full Text] [Related]
8. [An early phase II clinical study of RP56976 (docetaxel) in patients with breast cancer].
Taguchi T; Hirata K; Kunii Y; Tabei T; Suwa T; Kitajima M; Adachi I; Tominaga T; Shimada H; Sano M
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2453-60. PubMed ID: 7944491
[TBL] [Abstract][Full Text] [Related]
9. A dose escalation study of weekly docetaxel in patients with advanced solid tumors.
Kouroussis C; Agelaki S; Mavroudis D; Souglakos J; Kakolyris S; Kalbakis K; Vardakis N; Reppa D; Hatzidaki D; Samonis G; Georgoulias V
Cancer Chemother Pharmacol; 2000; 46(6):488-92. PubMed ID: 11138462
[TBL] [Abstract][Full Text] [Related]
10. A late phase II study of RP56976 (docetaxel) in patients with advanced or recurrent breast cancer.
Adachi I; Watanabe T; Takashima S; Narabayashi M; Horikoshi N; Aoyama H; Taguchi T
Br J Cancer; 1996 Jan; 73(2):210-6. PubMed ID: 8546908
[TBL] [Abstract][Full Text] [Related]
11. [Late phase II clinical study of RP56976 (docetaxel) in patients with advanced/recurrent breast cancer].
Taguchi T; Mori S; Abe R; Hasegawa K; Morishita Y; Tabei T; Sasaki Y; Fujita M; Enomoto K; Hamano K
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2625-32. PubMed ID: 7979423
[TBL] [Abstract][Full Text] [Related]
12. [Phase II clinical study of RP56976 (docetaxel) in patients with carcinoma ovarii or carcinoma colli uteri].
Noda K; Terajima Y; Ogita Y; Kono I; Hirabayashi K; Yakushiji M; Taguchi T
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2471-7. PubMed ID: 7944493
[TBL] [Abstract][Full Text] [Related]
13. Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer.
Hainsworth JD; Burris HA; Erland JB; Thomas M; Greco FA
J Clin Oncol; 1998 Jun; 16(6):2164-8. PubMed ID: 9626217
[TBL] [Abstract][Full Text] [Related]
14. Combination docetaxel/cyclophosphamide in patients with advanced solid tumors.
Valero V
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):34-6. PubMed ID: 9364540
[TBL] [Abstract][Full Text] [Related]
15. Phase I study of docetaxel with concomitant thoracic radiation therapy.
Mauer AM; Masters GA; Haraf DJ; Hoffman PC; Watson SM; Golomb HM; Vokes EE
J Clin Oncol; 1998 Jan; 16(1):159-64. PubMed ID: 9440738
[TBL] [Abstract][Full Text] [Related]
16. Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis.
Tomiak E; Piccart MJ; Kerger J; Lips S; Awada A; de Valeriola D; Ravoet C; Lossignol D; Sculier JP; Auzannet V
J Clin Oncol; 1994 Jul; 12(7):1458-67. PubMed ID: 7912725
[TBL] [Abstract][Full Text] [Related]
17. [Late phase II clinical study of RP56976 (docetaxel) in patients with non-small cell lung cancer].
Kudo S; Hino M; Fujita A; Igarashi T; Arita K; Niitani H; Taguchi T
Gan To Kagaku Ryoho; 1994 Nov; 21(15):2617-23. PubMed ID: 7979422
[TBL] [Abstract][Full Text] [Related]
18. Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: preliminary evidence of clinical activity.
Adjei AA; Klein CE; Kastrissios H; Goldberg RM; Alberts SR; Pitot HC; Sloan JA; Reid JM; Hanson LJ; Atherton P; Rubin J; Erlichman C
J Clin Oncol; 2000 Mar; 18(5):1116-23. PubMed ID: 10694565
[TBL] [Abstract][Full Text] [Related]
19. Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer.
Millward MJ; Zalcberg J; Bishop JF; Webster LK; Zimet A; Rischin D; Toner GC; Laird J; Cosolo W; Urch M; Bruno R; Loret C; James R; Blanc C
J Clin Oncol; 1997 Feb; 15(2):750-8. PubMed ID: 9053501
[TBL] [Abstract][Full Text] [Related]
20. A dose escalation study of docetaxel and oxaliplatin combination in patients with metastatic breast and non-small cell lung cancer.
Kouroussis C; Agelaki S; Mavroudis D; Kakolyris S; Androulakis N; Kalbakis K; Souglakos J; Mallas K; Bozionelou V; Pallis A; Adamtziki H; Georgoulias V
Anticancer Res; 2003; 23(1B):785-91. PubMed ID: 12680184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]